Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
Letters
CEI Joins Coalition Letter Opposing H.R. 3, the Lower Drug Costs Now Act
View Full Document as PDF Dear Member of Congress: We urge you to reject efforts to pass H.R. 3, the Lower Drug Costs…
Wall Street Journal
Vaccine Slowdown Isn’t Cause for Alarm
The United States has done something amazing: developed and authorized three new vaccines and vaccinated half of its adult population, all within 17 months of…
City Journal
Following the Politics, Not the Science
It is a disturbing prospect, like something out of a science fiction novel, but it’s appearing increasingly plausible nonetheless: the cause of the worldwide Covid-19…
Blog
The CDC Finally Does the Obvious
Calling Captain Obvious. The Centers for Disease Control and Prevention (CDC) has now stated what has been clear to anyone following the scientific literature for…
National Review
Punishing Success: the Biden Administration, Vaccines, and Intellectual Property
The Biden administration has apparently learned the wrong lessons from the COVID-19 pandemic. In a recent statement, U.S. Trade Representative Katherine Tai announced the “Biden-Harris Administration’s”…
The Center Square
Wyoming Becomes Latest State To Ban Vaccine Passports
The Center Square cites CEI’s study by Joel Zinberg: A recent study by the Competitive Enterprise Institute, a libertarian-leaning think tank, argued that…